FOLD has made public their rolling BLA to shareholders, but I do not know if FDA announced anything. I am pretty certain, the only reason we know is that the company chose to tell us so. It does beg the question as to whether or not they are obliged to tell us so as for a small company with one or no products, filing a BLA is obviously material.
Material information can be positive as well as negative and shareholders can be harmed by failing to reveal positive information in a timely manner.
Lets just say I sold the shares that I recently purchased between 1.40 and 1.90 before ASCO because I believed what was advertised to me at the Big Bar and ASCO 2019, but SNO comes and goes and I believe that no progress has been made because they have not told me so and I have not been given materially positive information. Instead with all my industry experience I believe we are seeing ENMD again.
Reasonable is reasonable, and material information is required to be delivered in a timely fashion without valid reason to withhold. If they feel the news is such that it requires a medical forum to adequately communicate the information to the public….I give you SNO.
What is that about a publication now? Yes, that too is an adequate forum but is it timely?
I can believe data was not ready for ASCO 2021, I cannot with reason believe this to be the case for SNO unless I am given a reason why. Why can I say this? Utah and Mt. Sinai
I want to know the data or I want to know WTF is going on and I do not care what that will do to stock price as I believe the stock price will drop significantly if we do not see data release at SNO and are not given an explanation.
AI
Market Data 
Markets 
